20-F/A

   1





 -----------------------------------------------------------------------------

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             ----------------------
                                 Form 20-F/A-1

/ /      Registration Statement Pursuant to Section 12(b) or 12(g) of the
         Securities Exchange Act of 1934 
                                      or
/X/      Annual Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange of 1934 
                                      or
/ /      Transition Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934

                 For the Transition period from ___________ to ___________

                        Commission file number 001-11145

                       BIOVAIL CORPORATION INTERNATIONAL
             (Exact Name of Registrant as Specified in its Charter)

                                 NOT APPLICABLE
                (Translation of Registrant's Name into English)

                                     CANADA
                (Jurisdiction of incorporation or organization)
                               2488 DUNWIN DRIVE
                              MISSISSAUGA, ONTARIO
                                CANADA, L5L 1J9
                    (Address of principal executive offices)

Securities registered or to be registered pursuant to Section 12(b) of the Act:
NONE

                        COMMON SHARES WITHOUT PAR VALUE
                                (Title of Class)

                            AMERICAN STOCK EXCHANGE
                     (Name of exchange on which registered)

Securities registered or to be registered pursuant to Section 12(g) of the Act:

Securities for which there is a reporting obligation pursuant to Section 15(d)
of the Act: NONE

Number of outstanding shares of the registrant's common stock as of December
31, 1995: 25,327,092 (after giving effect to a 3-for-1 stock split in January,
1996)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                             Yes    X     No _____

Indicate by check mark which financial statement item the registrant has
elected to follow.

                         Item 17   X     Item 18 _____
   2
                               TABLE OF CONTENTS

                              GENERAL INFORMATION

                                                                            PAGE





                                     PART I
                                (Not Applicable)


                                    PART II

                                (Not Applicable)


                                    PART III

                                (Not Applicable)


                                    PART IV

Item 19. Financial Statements and Exhibits . . . . . . . . . . . . . . . . ___



SIGNATURES
   3
D.       EXHIBITS FILED WITH THIS SUBMISSION

NUMBER              DESCRIPTION
       
21.1                Subsidiaries of the Registrant
       
                    Attached is Exhibit 21.1 of the Form 20-F for the
           year ended December 31, 1995.  The list of subsidiaries of the
           Registrant reflects the September 9, 1996 formation of Biovail
           Americas Corp., a Delaware corporation and a wholly-owned
           subsidiary of the Registrant.
       
   4
                                   SIGNATURES


Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the registrant certifies that it meets all of the requirements for filing
this Form 20-F/A-1 and has duly caused this Annual Report to be signed on its
behalf by the undersigned, thereunto duly authorized.


                                        BIOVAIL CORPORATION INTERNATIONAL


                                        /s/ Robert A. Podruzny 
                                        --------------------------------------
                                        Robert A. Podruzny
                                          Vice President - Finance and
                                          Chief Financial Officer



Date:  September 12, 1996
   5
                                EXHIBIT INDEX
                                -------------
                                      
             NUMBER                       DESCRIPTION
             ------                       -----------
       
              21.1                Subsidiaries of the Registrant
       

EX-21.1

   1
                                  EXHIBIT 21.1

Biovail Corporation International:

         Subsidiaries:

                 1.  Biovail SA, a Switzerland corporation; 
                 2.  Biosytes N.V., a Netherlands Antilles corporation; 
                 3.  Biovail Laboratories Incorporated, a Barbados corporation;
                 4.  Biovail [U.K.] Ltd., a United Kingdom corporation; and 
                 5.  Biovail Americas Corp. a Delaware corporation.